following: (1) A clear statement of the goals and objectives of the strategy. (2) A description of the activities and tools necessary to implement the strategy. (3) An identification of concrete benchmarks to judge progress in implementing the strategy. (4) A description of the programs and activities currently underway in support of the strategy. (5) Information on efforts and activities funded or implemented in foreign countries by other Federal agencies relevant to the strategy. (c) Priorities The strategy required under subsection (a), and the activities and assistance used to implement the strategy, should, at a minimum, prioritize the following: (1) Reducing the illicit production of opioids, including by better enforcement of controls to deny producers of illicit synthetic drugs access to precursor chemicals. (2) Strengthening the capacity of partner countries to detect, interdict, and share information on opioid threats. (3) Increasing the ability and political will of foreign countries to target online opioid sales, associated financial flows, and the use of postal systems and shipping services to transport illicit opioids, including fentanyl. (4) Improving the international legal framework for drug control to better keep pace with rapidly evolving synthetic drug threats. (5) Developing and enhancing partnerships with governments, industry, and international organizations to combat current and emerging opioid threats. (6) Supporting international efforts to decrease global demand for illicit opioids. (d) Report and update on strategy Not later than 90 days after the date of the enactment of this Act and annually thereafter for seven years, the Secretary of State shall submit to the appropriate congressional committees a report consisting of the following: (1) The strategy required under subsection (a). (2) Beginning with the second report required under this subsection, a list and description of the following: (A) Benchmarks achieved since the immediately preceding report. (B) Any United States programs